Fidelity Advisor Biotechnology Fund Total Current Liabilities

Fidelity Advisor Biotechnology Fund (FBTTX) currently reports a total current liabilities of $84M as of February 2024. That compares with $100M in the prior-year period — down 17.2% year over year. Use the charts on this page to explore Fidelity Advisor Biotechnology Fund's total current liabilities history and peer comparisons.

Fidelity Advisor Biotechnology Fund's total current liabilities decreased from $100M to $84M — a 17.2% year-over-year decrease (period ending February 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Fidelity Advisor Biotechnology Fund reported $84M in total current liabilities as of February 2024. That compares with $100M in the prior-year period — down 17.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $84M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Fidelity Advisor Biotechnology Fund, and consider following FBTTX for alerts when major investors trade the stock.